EVIDENCE BASED PUBLIC HEALTH POLICY AND PRACTICE

Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England

P R Ward¹, P R Noyce², A S St Leger³

¹ School of Social Science and Law, Sheffield Hallam University, Sheffield, UK
² School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK
³ Evidence for Population Health Unit, School of Epidemiology and Health Sciences, University of Manchester

Correspondence to:
Correspondence to:
Dr P R Ward
School of Social Science and Law, Collegiate Crescent Campus, Sheffield Hallam University, Sheffield S10 2BP, UK; p.r.ward{at}shu.ac.uk

Study objective: To analyse the associations between proxies of healthcare need and GP practice prescribing rates for five major coronary heart disease (CHD) drug groups.

Design: Cross sectional secondary analysis.

Setting: Four primary care trusts (PCTs 1–4) in the north west of England, encompassing 132 GP practices.

Results: Prescribing rates were generally positively associated with the percentage of patients aged 55–74 years and PASS-PUs (regionally specific prevalence, age, and sex standardised prescribing units). However, the percentage of patients aged over 75 years showed a lack of association with prescribing rates in all PCTs other than PCT2. Correlations with the proportion of South Asian patients were generally negative, particularly in PCT2, PCT4, and the combined dataset. There was a general lack of association with deprivation proxies and SMRs for CHD, although there were negative associations with both variables in PCT4 and the combined dataset. Scatter plots showed that GP practices with similar prescribing rates had widely differing levels of comparative healthcare need, and GP practices with similar levels of healthcare need had widely differing prescribing rates.

Conclusion: GP prescribing rates in some PCTs were negatively associated with proxies of healthcare need based on patient age (patients aged over 75 years), ethnicity, levels of deprivation, and SMRs for CHD. As such, this study suggests that prescribing rates in these PCTs may be inequitable as they are not positively associated with healthcare need. This study may form the baseline for further studies to assess the effectiveness of the NSF for CHD in reducing the inequities in prescribing rates.

Keywords: coronary heart disease; equity; GP prescribing

Abbreviations: CHD, coronary heart disease; PCT, primary care trust; NSF for CHD, National Service Framework for coronary heart disease; ADQ, average daily quantity; HCNI, health care needs indicator; LISI, low income scheme index; PASS-PU, prevalence, age and sex specific prescribing unit

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Prenatal origins of disease in later life and a fair amount of cardiovascular public health

Carlos Alvarez-Dardet, John R Ashton
J Epidemiol Community Health 2004 58: 81. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• McComb, J. M., Plummer, C. J., Cunningham, M. W., Cunningham, D. (2009). Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation rates. Europace 11: 1308-1312 [Abstract] [Full Text]  
• Livesey, S. (2009). Socio-economic deprivation and outcome in patients with coronary artery disease. Heart 95: 785-786 [Full Text]  
• Petty, D. R., Silcock, J. (2008). Explanations for variations in clopidogrel prescribing in England. J Public Health (Oxf) 30: 494-498 [Abstract] [Full Text]  
• McGovern, M. P, Boroujerdi, M. A, Taylor, M. W, Williams, D. J, Hannaford, P. C, Lefevre, K. E, Simpson, C. R (2008). The effect of the UK incentive-based contract on the management of patients with coronary heart disease in primary care. Fam Pract 25: 33-39 [Abstract] [Full Text]  
• Gnavi, R., Migliardi, A., Demaria, M., Petrelli, A., Caprioglio, A., Costa, G. (2007). Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities. Eur J Public Health 17: 492-496 [Abstract] [Full Text]  
• Bonovas, S., Filioussi, K., Flordellis, C. S., Sitaras, N. M. (2007). Statins and the Risk of Colorectal Cancer: A Meta-Analysis of 18 Studies Involving More Than 1.5 Million Patients. JCO 25: 3462-3468 [Abstract] [Full Text]  
• Ashworth, M., Lloyd, D., Smith, R. S., Wagner, A., Rowlands, G. (2007). Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'. J Public Health (Oxf) 29: 40-47 [Abstract] [Full Text]  
• Denvir, M A, Lee, A J, Rysdale, J, Walker, A, Eteiba, H, Starkey, I R, Pell, J P (2006). Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention.. J. Epidemiol. Community Health 60: 1085-1088 [Abstract] [Full Text]  
• Strong, M., Maheswaran, R., Radford, J. (2006). Reply. J Public Health (Oxf) 28: 294-294 [Full Text]  
• Strong, M., Maheswaran, R., Radford, J. (2006). Socioeconomic deprivation, coronary heart disease prevalence and quality of care: a practice-level analysis in Rotherham using data from the new UK general practitioner Quality and Outcomes Framework. J Public Health (Oxf) 28: 39-42 [Abstract] [Full Text]  
• Ward, P. R, Noyce, P. R, St Leger, A. S (2005). Multivariate regression analysis of associations between general practitioner prescribing rates for coronary heart disease drugs and healthcare needs indicators. J. Epidemiol. Community Health 59: 86-86 [Full Text]  

eLetters:

Read all eLetters

Ethnicity and Prescribing

Peter A West

J Epidemiol Community Health Online, 24 Feb 2004 [Full text]

Prescribing need is multifactorial

David C Lloyd

J Epidemiol Community Health Online, 24 Feb 2004 [Full text]